Can a Colorado resident get peptides by telehealth?
C.R.S. 12-240-107 lists the delivery of telemedicine as the practice of medicine, and C.R.S. 12-240-104(6) defines telemedicine as the delivery of medical services through HIPAA-compliant technologies including store-and-forward transfers. Colorado Medical Board Policy 40-27 says the practice of medicine occurs where the patient is located. A prescriber needs a Colorado license (the Interstate Medical Licensure Compact is one route) or, since January 1, 2026, an out-of-state telehealth registration under C.R.S. 12-30-124; a registered provider may not prescribe controlled substances. The Board's published policies (compilation dated May 2026) are guidance, not rules. Policy 40-03 (revised 2015) says a provider-patient relationship is established when the provider agrees to diagnose and treat and the patient agrees to be treated, whether or not there has been an in-person encounter, once the provider verifies the patient's identity and location, discloses the provider's identity and credentials, and obtains informed consent. Policy 40-27 (issued 2015, revised December 18, 2020 and August 19, 2021) defines telehealth to include store-and-forward transfers, says provider-patient relationships may be established using telehealth technologies in conformance with generally accepted standards of practice, calls for an appropriate medical evaluation and review of relevant clinical history before any prescription, and states that treatment, including a prescription, based solely on an online questionnaire does not constitute an acceptable standard of care. The policy says it does not itself set a standard of care. This record classifies asynchronous prescribing as allowed because both the Medical Practice Act definition and Board Policy 40-27 include store-and-forward transfers in telemedicine and the policy lets the relationship be established through telehealth technologies without requiring a real-time visit. A questionnaire-only intake does not qualify. [2] [3] [4] [5] [6] [18]
How does the Colorado pharmacy board treat compounding?
| Board | Colorado State Board of Pharmacy (Division of Professions and Occupations) |
|---|---|
| Eligible substances | Follows the federal 503A framework |
The Colorado State Board of Pharmacy regulates compounding under the Pharmacy Practice Act (C.R.S. Title 12, Article 280, including section 12-280-120 on compounding and dispensing) and Board rules at 3 CCR 719-1. Colorado has no separate state bulks list, so peptide eligibility follows the federal 503A framework (approved drug component, USP or NF monograph, or FDA 503A bulks list). Under C.R.S. 12-280-133, a prescription drug outlet outside Colorado that ships, mails, or delivers drugs into Colorado is a nonresident prescription drug outlet and must register with the Board, disclose its officers and the pharmacists dispensing to Colorado residents, keep its home-state license valid, and submit its most recent home-state inspection report. Board Rule 5.00.15 accepts an inspection by the home-state board or by a national pharmacy verification program dated within the previous two years and requires an affidavit that the outlet will not ship drugs into Colorado without a patient-specific prescription; an annual third-party inspection is required only for the separate case of distributing compounded products to Colorado veterinarians (Rule 21.00.20). Compounding standards are in Rule 21.00.00 of 3 CCR 719-1, and Rule 21.20.00 (Compounding of Sterile Products) with Rules 21.21.00 and 21.22.00 governs sterile preparations such as injectable peptides. The Board has a permanent rulemaking hearing set for October 1, 2026 on proposed revisions to its compounding rules to align them with recent FDA guidance. [1] [7] [9] [11] [12]
Can you get compounded GLP-1s in Colorado?
Colorado patients using a telehealth GLP-1 program should confirm the prescriber holds a Colorado license or an out-of-state telehealth registration and that an out-of-state dispensing pharmacy appears as a registered nonresident prescription drug outlet. The Board of Pharmacy rules (3 CCR 719-1) contain no GLP-1-specific provision, and a 2026 bill to regulate the marketing and distribution of compounded GLP-1 weight-loss medication (SB26-066) was postponed indefinitely in a House committee on May 5, 2026 and did not become law, so federal compounding limits and the general Colorado rules apply. [6] [7] [9] [10] [15] [16]
Prices by channel: semaglutide cost, tirzepatide cost.
Approvals, shortage history, and prices for every GLP-1 we track are on the GLP-1 hub.
What is the legal access path in Colorado?
Access options
Prescriber licensed in Colorado, in person or by telehealth
Telehealth prescribing of non-controlled peptides is permitted in Colorado. A prescriber may prescribe without a live visit (asynchronous care) when it meets the standard of care. State law says an online questionnaire alone is not enough.
Check the dispensing pharmacy against the board's license lookup before paying, including out-of-state mail-order pharmacies.
Branded GLP-1 through a retail or manufacturer pharmacy
FDA approved semaglutide and tirzepatide are available by prescription. Compounded GLP-1 limited; see the GLP-1 section for why.
CJC-1295 / Ipamorelin from Bodybuilding Peptides
SponsoredPartner lists from $220/month
Tesamorelin / Ipamorelin from Bodybuilding Peptides
SponsoredPartner lists from $274/month
Semax / Selank from Bodybuilding Peptides
SponsoredPartner lists from $274/month
We may earn a commission from these links.
Prices are the partner's own and are not verified by PeptideAgent. You answer health questions after checkout, and the partner's clinician decides whether to prescribe.
Unsponsored access paths are checked against public regulatory records. Sponsored offers are the partner's and are labeled. Products labeled research use only are never listed.
Find a provider in Colorado
What you'll actually find in Colorado, and how to check
Licensed compounding pharmacies, clinics, and telehealth prescribers openly offer many unapproved peptides, and prescribers write prescriptions for them. [21] [22] [23]
No FDA oversight of the specific product: FDA does not check a compounded drug's safety, effectiveness, or quality before it is sold. [24]
What Colorado has done
PeptideAgent has not found a board or legislative action on peptides in Colorado.
Other states have acted:
- On August 19, 2026, Mississippi's medical, nursing, and pharmacy boards said no licensed provider may prescribe, recommend, supply, or administer a peptide that is not FDA approved, and that a consent form does not remove the provider's liability. [26] Mississippi law
- Louisiana acted by statute: Act 374, in effect August 1, 2026, bars its licensing boards from prohibiting peptides only when they come from a pharmacy or outsourcing facility that complies with federal compounding law. It does not make any peptide eligible to compound. [27] [28] Louisiana law
Checking the prescriber
Telehealth prescribing of non-controlled peptides is permitted in Colorado. A prescriber may prescribe without a live visit (asynchronous care) when it meets the standard of care. State law says an online questionnaire alone is not enough. [2] [3] [4] [5] [6] [18] The telehealth rule in full.
Checking the pharmacy
Look the pharmacy up yourself before you pay, including an out-of-state mail-order pharmacy. The pharmacy regulator is the Colorado State Board of Pharmacy (Division of Professions and Occupations); its license search: FDA BeSafeRx: state board of pharmacy license lookups. [25]
If you're going ahead anyway
These steps lower some risks. They do not make a compounded product safe, and FDA has not reviewed it. [24]
They do not change a peptide's legal status either. That depends on the peptide: for a withdrawn nomination such as BPC-157 or TB-500, a 503A pharmacy has no federal basis to compound it from bulk, with or without a prescription, while a few Category 1 substances, such as NAD+ and glutathione, are compounded under FDA's interim policy, with conditions. Each peptide page gives its status. [13] [29] [30]
Check the pharmacy's license. Look the pharmacy up yourself on your state board of pharmacy's license search; FDA's BeSafeRx page links every state's. If the pharmacy is not listed, or is not licensed in your state, do not use it. [25] [31] [32]
What a legitimate prescription and consult look like. Federal law lets a pharmacy compound only for an identified patient on a valid prescription. A legitimate prescriber is licensed in the state where you are, evaluates you, and tells you the drug is compounded and not FDA approved, and a telehealth company should say which pharmacy compounds it. A seller that needs no prescription, or a pharmacy with no pharmacist to answer questions, is a warning sign. [23] [32] [33]
Why this is safer than a research-use-only product. A state-licensed pharmacy answers to its state board and has a pharmacist you can reach. A product labeled "research use only" or "not for human consumption" has neither, and FDA treats such products sold for people as unapproved drugs. In a 2024 study of semaglutide sold online without a prescription, half of six orders never arrived, and every vial that did was rated probably substandard or falsified, held more drug than its label said, and contained endotoxin. Black-market growth peptides have also contained modified molecules the label did not name. Safer is not safe: compounded drugs can also be contaminated or have too much or too little active ingredient. [24] [34] [35] [36] [37] [38]
Check for:
- A 503A pharmacy licensed in your state (your state board of pharmacy publishes license lookups). [24]
- A real evaluation by a licensed prescriber, not just an online form.
- A certificate of analysis for the specific batch.
Questions to ask
- Pharmacy: What is your license number, and are you licensed in my state? Then check it yourself on the state board's site. [25]
- Telehealth company: Which pharmacy compounds and ships this, and is it a 503A pharmacy or a 503B outsourcing facility? [23]
- Pharmacy: Is this made for me on a prescription written in my name? [33]
- Prescriber: Are you licensed where I am, and will you evaluate me yourself rather than rely on a questionnaire? [23] [32]
- Anyone offering it: Does anyone call it "FDA approved", "generic", or from an "FDA-approved pharmacy"? None of these is true of a compounded drug, so the claim is a red flag. [23]
What is offered for a specific peptide, and what FDA found, is on each peptide page.
Is it legal to buy research peptides in Colorado?
Only registered prescription drug outlets, including registered nonresident outlets, may dispense prescription drugs to Colorado patients. "Research use only" peptides sold for human injection are unapproved new drugs under federal law regardless of labeling and are not dispensed by a pharmacist. Colorado law also bars the sale directly: C.R.S. 12-280-131 says no person shall sell, deliver, offer for sale, hold for sale, or give away any new drug not authorized to move in interstate commerce under federal law, with an exception only for drugs intended solely for investigational use by qualified experts and plainly labeled for investigational use only. [7] [8] [17]
Peptide-specific notes for Colorado
| Peptide | Note |
|---|---|
| Semaglutide | Available branded by prescription, including by telehealth from a provider with a Colorado license or, since January 1, 2026, an out-of-state telehealth registration under C.R.S. 12-30-124. The Medical Board's telehealth policies say a prescription based solely on an online questionnaire is not acceptable care. Compounded semaglutide is limited to documented patient-specific needs since the 503A grace period ended April 22, 2025. [3] [6] [15] |
Frequently asked questions
Can a telehealth provider prescribe me a GLP-1 in Colorado without an in-person visit?
Yes, if the provider holds a Colorado license or a Colorado out-of-state telehealth registration and establishes a provider-patient relationship that meets generally accepted standards of practice. Colorado law lists the delivery of telemedicine as the practice of medicine, and Colorado law defines telemedicine to include store-and-forward transfers (C.R.S. 12-240-104(6)), and the Colorado Medical Board's telehealth policies, which are guidance, say the relationship may be formed through telehealth with appropriate informed consent. The policies do not require a real-time visit, but they say a prescription based solely on an online questionnaire is not acceptable care. [3] [4] [5] [6]
What does an out-of-state pharmacy need to ship compounded peptides to Colorado?
Registration as a nonresident prescription drug outlet with the Colorado State Board of Pharmacy under C.R.S. 12-280-133. The outlet must submit a recent inspection report from its home-state board or a national pharmacy verification program, keep its home-state license valid, and ship compounded drugs into Colorado only on patient-specific prescriptions, so check the Division of Professions and Occupations license lookup before ordering. [1] [7] [9]
What Colorado-specific rules apply to GLP-1 programs?
Colorado patients using a telehealth GLP-1 program should confirm the prescriber holds a Colorado license or an out-of-state telehealth registration and that an out-of-state dispensing pharmacy appears as a registered nonresident prescription drug outlet. Colorado has no GLP-1-specific pharmacy rule; a 2026 bill aimed at compounded GLP-1 weight-loss medication (SB26-066) did not become law. [6] [7] [10] [15] [16]
Can a Colorado pharmacy compound BPC-157?
Only under a draft federal policy, and only within strict limits. On October 28, 2026 HHS released a draft enforcement discretion policy saying it will not take enforcement action against a state-licensed pharmacy that compounds BPC-157 as a single-ingredient product by an allowed route, on a patient-specific prescription, from an FDA-registered manufacturer's substance with a tested certificate of analysis, with serious adverse events reported to FDA. BPC-157 is still not FDA approved or on the 503A bulks list, the policy is not binding and HHS may revisit it, and blends such as Wolverine are not covered. FDA's drug center recommended against listing BPC-157; the advisory committee voted in favor (HHS policy, Appendix B). State law still applies: Colorado has no separate state bulks list, so peptide eligibility follows the federal 503A framework. [11] [13] [14] [19] [20]
Sources
Numbered citations above point to these primary sources: the state statute or rule, the pharmacy board, federal FDA guidance, and the FDA warning letters and studies behind what is offered.
- [1]Colorado State Board of Pharmacy, Division of Professions and Occupations
- [2]Colorado Medical Board, Division of Professions and Occupations
- [3]Colorado Medical Board Policies, compilation dated May 2026 (Policy 40-03 provider-patient relationship; Policy 40-27 telehealth guidelines, revised August 19, 2021), linked from the Board homepage, accessed 2026-09-30
- [4]C.R.S. 12-240-107, Practice of medicine defined (includes telemedicine)
- [5]C.R.S. 12-240-104, Definitions (subsection (6), telemedicine includes store-and-forward transfers), accessed 2026-09-30
- [6]C.R.S. 12-30-124, telehealth by providers with an out-of-state credential who register with a Colorado regulator (added by SB 24-141; Justia 2025 edition), accessed 2026-09-30
- [7]C.R.S. 12-280-133, Nonresident prescription drug outlet, registration, accessed 2026-09-22
- [8]C.R.S. 12-280-131, New drugs, when sales permissible, accessed 2026-09-22
- [9]Colorado Secretary of State, Code of Colorado Regulations 3 CCR 719-1, State Board of Pharmacy Rules (current version effective August 21, 2026; Rules 5.00.15, 21.00.00, 21.20.00), accessed 2026-09-22
- [10]Colorado General Assembly: SB26-066, Regulation of Compounded Weight-Loss Medication (postponed indefinitely May 5, 2026), accessed 2026-09-22
Cite this page
Free to cite and quote with a link. Data is licensed CC BY 4.0 with attribution to PeptideAgent.
- APA style
PeptideAgent. (2026, October 28). Are peptides legal in Colorado?. https://peptideagent.ai/legal/colorado- HTML link
<a href="https://peptideagent.ai/legal/colorado">Are peptides legal in Colorado?</a>, PeptideAgent, updated October 28, 2026.